The kit is designed for detection of 16 germline(blood) /Somatic (Tissue) mutations in the BRCA1 and BRCA2 genes.
The kit diagnose melanoma, papillary thyroid cancer, ovarian, colorectal and prostate cancer to determine indications for targeted therapy.
The kit examine patient diagnosed with non-small cell lung cancer (NSCLC) to determine indications for targeted therapy.
The kit examines patients diagnosed with colorectal cancer to determine indications for targeted therapy.
The kit examines patients diagnosed with colorectal cancer in KRAS region.
The kit is designed for early non-invasive diagnosis of prostate cancer by detection of the TMPRSS2-ERG chimeric gene.
The kit is designed for detection of 16 germline mutations in the HRR genes.
The kit is designed for detection of DNA of 12 pathogens of urogenital infections.
The kit is intended for diagnostics of the respiratory viral infection caused by the SARS-CoV-2 coronavirus.
The kit is designed for diagnostics of the respiratory viral infection caused by the SARS-CoV-2 coronavirus.
The kit is designed for diagnostics of the respiratory viral infection caused by the SARS-CoV-2.
The kit is designed for quantitative detection of the hepatitis B virus DNA.
The kit is designed for quantitative detection of the hepatitis C virus RNA in patients.
The kit is designed for qualitative and quantitative detection of hepatitis D virus RNA in patients with suspected.
The kit is designed for detection of the hepatitis C virus and its genotypes (1a,1b, 2, 3, 4, 5a, 6) in patients.
The kit is designed for detection and differentiation of the hepatitis B, C and D viruses in patients.
The kit detect and differentiation of human immunodeficiency viruses type 1 and 2 (HIV-1 and HIV-2).
The kit is designed for quantitative detection of the human immunodeficiency virus (HIV-1).
The kit is recommended for use in patients with clinical symptoms of malaria with a suspected infection.
A short summary of a webpage's content that appears in search engine results.
It is intended for use in patients with symptoms of a viral disease with a infection caused by Dengue virus.
It is intended for use in patients with symptoms of a viral disease with a infection caused by Zika virus.
It is intended for use in patients with clinical symptoms of a viral disease with a suspected Chikungunya virus.
It is intended for use in patients with symptoms of a viral disease with a infection caused by Tropic disease.
The kit is designed for qualitative and quantitative detection of human herpes simplex virus type 6 (HHV-6) DNA. It is used when examining patients.
The kit is designed for detection of the tuberculosis and non-tuberculosis complex mycobacteria.
The kit is designed for detection of mutations associated with drug resistance in the tuberculosis complex mycobacteria DNA.
The kit is designed to detect polymorphisms associated with drug resistance to second-line chemotherapy drugs.
The kit is designed for isolation of DNA/RNA from human clinical material by the method based on magnetic particles for subsequent PCR tests.
The kit is designed for semi-automatic simultaneous extraction of DNA/RNA from human clinical material.
The kits are designed for isolation of human DNA from plasma samples by the method based on the reversible binding of nucleic acids.
The kits are designed for isolation of human DNA from formalin-fixed paraffinembedded tissues (FFPE blocks).
The kit is designed for collection, transportation and isolation of DNA from clinical material.
